Search
Search Results
##search.searchResults.foundPlural##
-
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1775PDF: 901HTML: 1292Figure 1: 218Figure 2: 231Figure 3: 232 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1581PDF: 904HTML: 3154 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7998PDF: 2542HTML: 2178Table 1.: 278Table 2.: 298Table 3.: 271Table 4.: 270 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2260PDF: 849HTML: 1096Spirometry in SCA patients before transplant: 259Spirometry in SCA patients post transplant: 236 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2774PDF: 1061HTML: 15157 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
6001PDF: 1626HTML: 1687Untitled: 287 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4729Suppl. Files: 1282PDF: 1185Html: 335 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1787PDF: 1163HTML: 515 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1685PDF: 862HTML: 1549Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 228 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1823PDF: 1179HTML: 200 -
IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES
1151PDF: 713HTML: 282 -
CAN WE PREDICT INCIPIENT DIABETES MELLITUS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (β-TDT) REFERRED WITH A HISTORY OF PREDIABETES? Risk factors for incipient diabetes in thalassemia
1234PDF: 1442HTML: 187 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1828PDF: 1412HTML: 188 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1918PDF: 632HTML: 422 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1418PDF: 1043HTML: 112 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3446PDF: 1122HTML: 2603 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4501PDF: 2060HTML: 5570Table 1: 300 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2473PDF: 1125HTML: 2435 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2357PDF: 938HTML: 387 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2732PDF: 1267HTML: 178 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
4019PDF: 1610HTML: 366 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
2084PDF: 754HTML: 2461Untitled: 209Figure 1 a: 215Figure 1 b: 219Fig 1 c: 198Figure 1 d: 262 -
ASSOCIATION OF VDBP RS4701 VARIANT, BUT NOT VDR/RXR-? OVER-EXPRESSION WITH BONE MINERAL DENSITY IN PEDIATRIC ?-THALASSEMIA PATIENTS Vitamin D metabolic axis and BMD in ?-thalassemia
1430PDF: 805HTML: 302 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3985PDF: 1343HTML: 5104Incidence age-standardized rates for HL across the Mediterranean basin: 260 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1359PDF: 639HTML: 289 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1367PDF: 1019HTML: 356 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1344PDF: 575HTML: 438







